Table 1. Patients' characteristics.
| N | % | |
|---|---|---|
| Total | 528 | |
| Age | ||
| (Median range) | 54 (29-87) | |
| —39 | 50 | 9.5 |
| 40-49 | 118 | 22.3 |
| 50-59 | 225 | 42.6 |
| 60-69 | 99 | 18.8 |
| 70— | 34 | 6.4 |
| FIGO stage | ||
| I | 372 | 70.5 |
| IA | 102 | 19.3 |
| IB | 2 | 0.4 |
| IC1 | 170 | 32.2 |
| IC2 | 51 | 9.7 |
| IC3 | 47 | 8.9 |
| II | 81 | 15.3 |
| III | 75 | 14.2 |
| Period of initial treatment | ||
| —1999 | 105 | 19.9 |
| 2000-2004 | 107 | 20.3 |
| 2005-2009 | 143 | 27.1 |
| 2010— | 173 | 32.8 |
| Chemotherapy | ||
| Platinum-based | 81 | 15.3 |
| Taxane plus platinum | 344 | 65.2 |
| Others | 11 | 2.1 |
| None | 68 | 12.9 |
| Unknown | 24 | 4.5 |
| CA125 value | ||
| ≤ 35 U/mL | 180 | 34.1 |
| > 35 U/mL | 330 | 62.5 |
| Unknown | 18 | 3.4 |
FIGO: International Federation of Gynecology and Obstetrics, IC substage was defined according to FIGO 2014 classification.